Evid Invest
Who owns XLOWhat XLO owns — n/a

Who owns Xilio Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of XLO from SEC Form 13F filings across 29 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 29 institutions disclosed 3.1M shares of Xilio Therapeutics, Inc. worth $28.3M — about 15.9% of shares outstanding; the largest disclosed holder is Bain Capital Life Sciences Investors, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

29

13F holders

$28.3M

value, 2026 filers

15.9%

of shares outstanding (3.1M sh)

7

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of XLO's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Bain Capital Life Sciences Investors, LLC664,021$6.0M0.4%3.4%0.0%
2ORBIMED ADVISORS LLC592,300$5.4M0.1%3%0.0%
3ADAGE CAPITAL PARTNERS GP, L.L.C.464,598$4.2M0.0%2.4%+316.5%
4Frazier Life Sciences Management, L.P.422,505$3.8M0.1%2.1%0.0%
5VANGUARD CAPITAL MANAGEMENT LLC198,181$1.8M0.0%1%+11.0%
6Stonepine Capital Management, LLC189,092$1.7M1.1%1%-16.3%
7Sio Capital Management, LLC152,464$1.4M0.3%0.8%0.0%
8Merck & Co., Inc.105,982$959,1370.1%0.5%0.0%
9RENAISSANCE TECHNOLOGIES LLC63,553$575,1550.0%0.3%-0.9%
10MORGAN STANLEY53,674$485,7500.0%0.3%-5.8%
11GEODE CAPITAL MANAGEMENT, LLC41,449$375,1400.0%0.2%+6.1%
12TWO SIGMA INVESTMENTS, LP40,104$362,9410.0%0.2%+175.7%
13VANGUARD FIDUCIARY TRUST CO28,193$255,1470.0%0.1%+24.8%
14BRIDGEWAY CAPITAL MANAGEMENT, LLC17,544$158,7730.0%0.1%0.0%
15GSA CAPITAL PARTNERS LLP16,673$151,0000.0%0.1%+22.7%
16STATE STREET CORP13,311$120,4650.0%0.1%0.0%
17PRUDENTIAL FINANCIAL INCNEW13,180$119,2790.0%0.1%new
18HRT FINANCIAL LPNEW12,453$112,0000.0%0.1%new
19NORTHERN TRUST CORPNEW11,650$105,4330.0%0.1%new
20CITADEL ADVISORS LLC11,061$100,1020.0%0.1%-57.4%
21BlackRock, Inc.10,908$98,7180.0%0.1%+24.6%
22Vanguard Global Advisers, LLCNEW3,359$30,3990.0%0%new
23Steward Partners Investment Advisory, LLC714$6,4620.0%0%0.0%
24UBS Group AG544$4,9240.0%0%+3785.7%
25ROYAL BANK OF CANADANEW98$1,0000.0%0%new

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.
EvidInvest Pro: unlimited filings data, $50/month